Twelve-month immunogenicity and safety of an adjuvanted recombinant zoster vaccine in immunosuppressed adults post renal transplant: A phase III randomized clinical trial

Authors
Category Primary study
JournalOpen Forum Infectious Diseases
Year 2018
This article has no abstract
Epistemonikos ID: efdc620fd61fbbf10f32fc27da92e0bf43802557
First added on: Feb 11, 2025